American Society of Hirudotherapy

Challenges in measuring outcomes following digital replantation

Research article published in Seminars in plastic surgery (2013)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportClinical TrialsSebastin et al. · Seminars in plastic surgery, 2013

Abstract

In the early period of replantation surgery, the emphasis was on digit survival. Subsequently, with better microsurgical techniques and instrumentation, the focus has shifted to function and in recent years to consideration of cost-effectiveness. Despite over 40 years of effort in refining digital replantation surgery, a rigorous evaluation of the outcomes of digital replantation has not been performed. This is because of the many confounding variables that influence outcome comparisons. These variables include the mechanism of injury (guillotine, crush, avulsion), the injury itself (total, near total, subtotal, partial amputation), and the surgical procedure (replantation, revascularization). In addition, the traditional outcome measures (two-point discrimination, range of motion, grip strength, or the ability to return to work) are reported inconsistently and vary widely among publications. All these factors make meaningful comparison of outcomes difficult. The recent emphasis on outcome research and cost-effectiveness necessitates a rethinking in the way we report outcomes of digital replantation. In this article, the authors summarize the challenges in assessing outcomes of digital replantation and explain the need to measure outcomes using rigorous clinical research designs that incorporate cost-effectiveness studies in the research protocol.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Summary

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Why This Matters for Hirudotherapy

This article argues that despite decades of refinement in digital replantation, rigorous outcome evaluation has been hampered by confounders such as injury mechanism, amputation type, and procedure, and by inconsistent reporting of measures like two-point discrimination, range of motion, grip strength, and return to work, and it calls for standardized, cost-effectiveness-aware research designs. For hirudotherapy this is a useful methodological caution: because leeches are used as an adjunct to salvage congested replants, the same heterogeneity and inconsistent endpoints that make replantation outcomes hard to compare also make it difficult to isolate or quantify any contribution of leech therapy from published series. This is a conceptual review of measurement problems, not original outcome data, so it supports cautious interpretation of the replantation literature rather than any claim about leech efficacy.

Citation

Challenges in measuring outcomes following digital replantation.

Sebastin et al. · Seminars in plastic surgery, 2013

Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.